Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a minor system update and does not change the study content.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page's revision label was updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a newer version of the page's content in the revision history. This update reflects an administrative version control change rather than a change to study data or visible content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was updated. The page also indicates that recruitment is no longer open to participants.SummaryDifference0.4%

- Check29 days agoChange DetectedRevision: v3.5.5 was added, replacing the previous Revision: v3.5.4. This reflects a minor update to the page's revision metadata for the study record.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, indicating an internal update to the study record display.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s footer updated the displayed software/version revision from **v3.5.2** to **v3.5.3**. This represents an administrative release or UI update rather than a change to the clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.